Allele-specific splicing modulates protein isoforms and Alzheimer's disease risk
Genome Research · 2026
DOI: 10.1101/gr.281117.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2026. Verfasst von Alison J King und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Interdepartmental Program, University of California, Los Angeles, California 90095, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Alternative Splicing, Alleles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: National Institutes of Health, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Despite growing catalogs of genetic variation linked to human traits and diseases, the functional impact of most genetic variants remains poorly understood. Alternative splicing, particularly in the human brain, represents a key layer of post-transcriptional regulation that may mediate genetic effects on gene expression and protein diversity. In this study, we systematically map allele-specific alternative splicing (ASAS) events in postmortem brain tissues from the Mount Sinai Brain Bank cohort, identifying hundreds of genetically regulated splicing events across four brain regions. Using a concordance-based method, we nominate more than 500 putative functional SNPs associated with ASAS, many of which overlap splicing QTLs (sQTLs), RNA-binding protein binding sites, and GWAS loci for Alzheimer's disease (AD), brain traits, and immune phenotypes. ASAS events are enriched in genes involved in mitochondrial function and frequently occur in 5′ untranslated regions (5′ UTRs), in which they are associated with protein quantitative trait loci (pQTLs), alternative start codons, and isoform-specific domain changes, highlighting an underappreciated mechanism through which noncoding variants can influence translation and proteome complexity. Importantly, we also identify a subset of ASAS events exhibiting disease-specific splicing patterns in AD brains, including functional SNPs with opposing splicing effects between AD and control groups in genes implicated in mitochondrial function and neuronal signaling. Together, our results provide a brain-specific, splicing-resolved map of regulatory variation and uncover novel mechanisms linking genetic variation to transcript- and protein-level changes in AD. This work highlights the importance of allele-specific splicing analysis for interpreting noncoding variation in complex human disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics Interdepartmental Program, University of California, Los Angeles, California 90095, USA.
- Department of Integrative Biology and Physiology, University of California, Los Angeles, California 90095, USA.
- Bioinformatics Interdepartmental Program, University of California, Los Angeles, California 90095, USA; gxxiao@ucla.edu.
Förderung
- National Institutes of Health
- National Institute on Aging
Zitieren
APA
King, A. J., Amoah, K., Zhang, L., Bahn, J. H., Barney, R. M., Quinones-Valdez, G., & Xiao, X. (2026). Allele-specific splicing modulates protein isoforms and Alzheimer's disease risk. Genome Research. https://doi.org/10.1101/gr.281117.125
Vancouver
King AJ, Amoah K, Zhang L, Bahn JH, Barney RM, Quinones-Valdez G, et al. Allele-specific splicing modulates protein isoforms and Alzheimer's disease risk. Genome Research. 2026. doi:10.1101/gr.281117.125
BibTeX
@article{King2026,
author = {King, Alison J and Amoah, Kofi and Zhang, Laixing and Bahn, Jae Hoon and Barney, Ryan M and Quinones-Valdez, Giovanni and Xiao, Xinshu},
title = {Allele-specific splicing modulates protein isoforms and Alzheimer's disease risk},
journal = {Genome Research},
year = {2026},
doi = {10.1101/gr.281117.125}
}
EUVIMED